- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ABT
Recent news which mentions ABT
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
October 26, 2023
From Motley Fool
Stocks to own ahead of a rally that this $15 billion fund house says is coming soon
October 25, 2023
From MarketWatch
Tickers
ABT
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 23, 2023
From Benzinga
7 Blue-Chip Stocks to Buy on the Dip
October 19, 2023
Tags
DIS
NYSE:NKE,NASDAQ:QCOM,NYSE:ABT,NYSE:DIS,NASDAQ:CHTR,NYSE:EL,NYSE:BUD,NYSE:TAP,OTCMKTS:NTDOY
QCOM
From InvestorPlace
These Analysts Cut Their Forecasts On Abbott After Q3 Results
October 19, 2023
Tickers
ABT
From Benzinga
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
October 18, 2023
Tickers
ABT
From Motley Fool
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
October 18, 2023
From Benzinga
Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook
October 18, 2023
Tickers
ABT
From Benzinga
Abbott Labs’ stock rises as third-quarter results beat estimates despite plunging COVID sales
October 18, 2023
From MarketWatch
US Stocks Set For Weak Open Ahead Of Tesla Q3 Print: Why This Analyst Is Skeptical Of S&P 500 Recovery To Early 2022 High
October 18, 2023
From Benzinga
Earnings Scheduled For October 18, 2023
October 18, 2023
From Benzinga
Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns
October 16, 2023
From Benzinga
Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate
October 16, 2023
From Benzinga
A Look Into Abbott Laboratories Inc's Price Over Earnings
October 16, 2023
Tickers
ABT
From Benzinga
Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?
October 16, 2023
From Benzinga
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 14, 2023
From Motley Fool
Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets
October 13, 2023
From Benzinga
Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily
October 13, 2023
From Benzinga
As Isreal-Palestine Conflict Escalates, Gold Ticks Up - ETF Winners And Losers: Medium-Cap Returns
October 12, 2023
From Benzinga
Abbott Laboratories Unusual Options Activity For October 12
October 12, 2023
Tickers
ABT
From Benzinga
Why Medtronic And Abbott Stocks Are Sinking
October 11, 2023
From Benzinga
Abbott Laboratories Explores Consumer Wearables Market As COVID Testing Sales Dwindle: CEO
October 11, 2023
Tickers
ABT
From Benzinga
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
October 11, 2023
From Benzinga
3 Dividend Kings Every Investor Should Own to Survive a Market Crash
October 10, 2023
From InvestorPlace
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October
October 09, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.